Founded in 2008, Epigeneres Biotech operates in Health Tech industry. Initially targeting personalized healthcare solutions, the company has since diversified its offerings to include innovative cance...
Funding stage:
Series B
Last funding:
21/01/2022
Total funding:
$12.00 Mn+
Revenue:
Investors
Employee count:
85
Last 90d
85
Last 90d
Web traffic:
1.47K
1.47K
Last 30d
Last 30d
Glassdoor Rating:
Epigeneres Biotech: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders61
Latest Filing Date02 Oct 2024- Funding Events24
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Epigeneres Biotech
As of 03 October 2024, Epigeneres Biotech's equity is held by 59 shareholders, with the top three being Usha Vinaykumar Tripathi, Ashish Vinay Kumar Tripathi, and Amish Tripathi.
Usha Vinaykumar Tripathi holds the largest stake in Epigeneres Biotech at 15.3% as of 03 October 2024.
As of 03 October 2024, founders collectively hold 2.1% equity in Epigeneres Biotech.
As of 03 October 2024, investors collectively hold 7.0% equity in Epigeneres Biotech.
Epigeneres Biotech's ESOP pool stands at 46.7% of total equity as of 03 October 2024.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links